2022---dr--martens-sieht-gewinnausf-lle-und-erh-ht-die-dividende-um-28-----magazin--gesundheits--und-sportnachrichten

: The report from Magazin Gesundheits- und Sportnachrichten highlighted these figures during a period of global economic uncertainty and a "challenging consumer backdrop".

: Growth was balanced globally, though the Dr. Martens PLC Annual Report 2022 noted that "Originals" (classic boots like the 1460) remained the core revenue driver at 51%. bbc.com/news/articles/cm2kpwnr4rjo">BBC News ? DR. MARTENS PLC ANNUAL REPORT 2022 : The report from Magazin Gesundheits- und Sportnachrichten

: Lower EBITDA margins were attributed to planned investments in new stores , marketing, and technology, as well as rising cost inflation which the company aimed to offset with price increases in 2023. The following metrics summarize the performance as of

The following metrics summarize the performance as of late 2022: £418.6 million +18% (11% CC) Direct-to-Consumer (DTC) Revenue Noted as a primary driver Profit Before Tax £57.9 million Under pressure from cost inflation EBITDA Margin -2.8 percentage points Interim Dividend 1.56p per share Analysis of the Report : The report from Magazin Gesundheits- und Sportnachrichten

In 2022, Dr. Martens reported a mixed financial performance, characterized by alongside profitability pressures that led to a significant dividend increase . While the company achieved an 18% growth in underlying revenue during the first half of its financial year, it simultaneously faced "profit shortfalls" in the form of lower margins due to ongoing investments and a weakening economic environment. Key Financial Highlights (FY23 H1)

: The 28% dividend increase was a deliberate signal of management's "confidence in the future" despite the profit headwinds. This payout represented roughly 35% of earnings.